Transcripts
TScan Therapeutics (TCRX) earnings call transcripts
Earnings call transcripts for TScan Therapeutics, Inc., with a summary, the guidance given, and what analysts pressed on.
- business update, September 1, 2026
Management repositioned TScan around two in-vivo solid-tumor candidates while pausing underfunded heme development and seeking partnerships.
Sep 02, 2026Mildly positive0.35